How many clinical trials are studying ZL-1310?

3 recruiting trials in our tracked data involve ZL-1310.

What conditions is ZL-1310 being studied for?

In our tracked recruiting trials, ZL-1310 is being studied in trials for Lung cancer, Small Cell Lung Cancer, SCLC.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 1 2 Phase 3 1

Condition	Trials
Lung cancer · ZL-1310 for Lung cancer	3
Small Cell Lung Cancer	2
SCLC	1

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
NCT07218146 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 155 locations
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
NCT06179069 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 38 locations
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
NCT07531095 · Phase: Phase 1 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 27 locations